000 01165 a2200385 4500
005 20250513110137.0
264 0 _c19970115
008 199701s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/S0140-6736(05)65859-X
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRintelen, C
245 0 0 _aOral anticoagulants and fetal loss.
_h[electronic resource]
260 _bLancet (London, England)
_c
300 _a1735 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAbortion, Spontaneous
_xetiology
650 0 4 _aAdult
650 0 4 _aFactor V
650 0 4 _aFactor V Deficiency
_xcomplications
650 0 4 _aFemale
650 0 4 _aFetal Death
_xetiology
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aMutation
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications, Hematologic
650 0 4 _aRisk
700 1 _aMannhalter, C
700 1 _aPabinger, I
700 1 _aScharrer, I
700 1 _aKlinke, S
773 0 _tLancet (London, England)
_gvol. 348
_gno. 9043
_gp. 1735
856 4 0 _uhttps://doi.org/10.1016/S0140-6736(05)65859-X
_zAvailable from publisher's website
999 _c8965156
_d8965156